Challenges to Early Discharge of Patients with Upper Urinary Tract Infections by ESBL Producers: TMP/SMX as a Step-Down Therapy for Shorter Hospitalization and Lower Costs

BACKGROUND: Urinary tract infections (UTIs) caused by extended spectrum beta-lactamase (ESBL) producing pathogens have increased and are treated with carbapenem in general. Carbapenem use is associated with prolonged hospitalization or daily outpatient visit. The aim of this study was to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Hye Jin, Wee, Jae Hee, Eom, Joong Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422030/
https://www.ncbi.nlm.nih.gov/pubmed/34511950
http://dx.doi.org/10.2147/IDR.S321888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422030/
https://www.ncbi.nlm.nih.gov/pubmed/34511950
http://dx.doi.org/10.2147/IDR.S321888

Ejemplares similares